<DOC>
	<DOC>NCT00610727</DOC>
	<brief_summary>To evaluate the tolerability and safety of inhaled prochlorperazine To evaluate the pharmacokinetics of inhaled prochlorperazine</brief_summary>
	<brief_title>Staccato Prochlorperazine Single Dose PK</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Prochlorperazine</mesh_term>
	<criteria>Subjects will be male or female subjects between the ages 18 to 45 years, inclusive in good general health as determined by medical history, physical examination, 12lead ECG, spirometry, blood chemistry profile, hematology, urinalysis and in the opinion of the Principal Investigator. Subjects with a known history of allergy or intolerance to phenothiazines or related drugs or who have any disease, by history, physical examination, or laboratory abnormalities that in the investigator's opinion, would present undue risk to the subject, or may confound the interpretation of study results.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Migraine, Prochlorperazine aerosol</keyword>
</DOC>